# Compare GHK-Cu, BPC-157 and Ipamorelin — Pure Amino Peptides

> Side-by-side comparison of GHK-Cu, BPC-157 and Ipamorelin: molecular class, mechanism, species studied, evidence maturity, regulatory status, WADA status.

Same frame — peptide chemistry — different structures, different receptors, very different evidence profiles.

## The short version

GHK-Cu, BPC-157, and Ipamorelin are all synthetic peptides studied for distinct purposes, but they differ dramatically in length, chemistry, mechanism, and how much human data backs them. GHK-Cu is a three-amino-acid copper complex with real topical human trial data. BPC-157 is a fifteen-amino-acid sequence with thirty years of animal data and almost no human trials. Ipamorelin is a five-amino-acid engineered synthetic with a known receptor, a failed human RCT, and no approved use. Structure drives function in each case — and the comparison below is most useful when read through that lens.

## Comparison table

| Feature | GHK-Cu | BPC-157 | Ipamorelin |
|---|---|---|---|
| **Chain length** | 3 amino acids | 15 amino acids | 5 amino acids |
| **Sequence origin** | Natural (collagen fragment) | Semi-natural (gastric BPC protein) | Fully synthetic (GHRP-1 derivative) |
| **Key structural feature** | Cu(II) chelate via His imidazole | Triple proline (Pro-Pro-Pro) confers protease resistance | D-amino acids (D-2-Nal, D-Phe) + Aib; engineered protease resistance |
| **Primary receptor / target** | Dermal fibroblasts, lysyl oxidase, gene expression | VEGFR2 (angiogenesis); also FAK-paxillin, eNOS, GH receptor | GHS-R1a (ghrelin receptor) on pituitary somatotrophs |
| **What it is studied for** | Skin aging, collagen synthesis, wound healing, hair growth | Tissue repair (tendon, gut, muscle, nerve), angiogenesis | GH secretion, postoperative gut motility |
| **Main species studied** | Human (topical skin + hair RCTs), rat/in vitro | Rat (predominantly); 2 human safety reports | Rat/swine; human PK/PD; 1 human RCT |
| **Evidence maturity** | Controlled topical human data (small n); mechanistic and animal data; broad gene-expression claims less replicated | Three decades of animal data; three small human pilots; no rigorous large human trial | Human PK/PD characterized; Phase 2 RCT (missed endpoint); no approved indication |
| **Regulatory status** | Topical Copper Tripeptide-1: legal cosmetic ingredient (US, EU). Injectable/systemic: unapproved research chemical | Not approved anywhere; not eligible for 503A compounding; research chemical only | Never approved; FDA removed from 503A Category 2 list (2024); research chemical only |
| **WADA status** | Not currently listed on WADA Prohibited List | Prohibited (S0 non-approved substances) at all times | Prohibited (S2 peptide hormones / GH secretagogues) at all times |
| **Human dosing established** | No (topical formulations only; no human PK for systemic use) | No (no PK in humans) | Partially (IV PK/PD in volunteers; SC route not characterized) |

## Reading the comparison

A few patterns stand out when the three are lined up:

**Chemistry determines survival.** GHK-Cu's copper chelate determines most of its biological activity — not just transport. BPC-157's triple proline is the structural reason it can survive acid. Ipamorelin's D-amino acids and Aib are deliberate engineering for protease resistance. In each case, the chemistry is not just description; it explains why the peptide can do what it is claimed to do.

**Human evidence is uneven.** GHK-Cu has the most controlled human data, but only for topical skin and hair applications. Ipamorelin has published human PK data and a controlled trial (which failed). BPC-157 has almost none — a two-person safety pilot and two other small reports. Preclinical breadth does not substitute for human trials, and none of these is an approved medicine.

**WADA status matters for athletes.** Two of the three — BPC-157 (S0) and Ipamorelin (S2) — are prohibited in competitive sport with established detection methods. GHK-Cu is currently not listed. Anyone in a sport subject to anti-doping control should check the current WADA Prohibited List directly before any research use.

**All three are research chemicals (or, for GHK-Cu, cosmetic ingredients topically).** This framing applies consistently across the desk: peer-reviewed citations, plain-English summaries, no medical advice, no doses.

---

A literature digest built around the chemistry — sequence, structure, mechanism, evidence — not the marketing.